Autopsy report · NCT00524589
Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Cause of deathFutility
“closed due to futility”
Life of this trial
- Registered 1 year 5 months after it had already started.
- Ran for about 4 years 5 months before it stopped.
- 18 participants enrolled.
- Results were posted on the registry 3 years 6 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Roswell Park Cancer Institute
- Sponsor type
- University, hospital or other
- Conditions
- Prostate Cancer
- Interventions
- calcitriol; dexamethasone; protein expression analysis; laboratory biomarker analysis
- Participants
- 18
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Personalized Treatment Selection for Metastatic Breast Cancer
“Closed early for futility.” - Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease
“Closed due to low accrual” - Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype
“Closed due to very slow accrual” - S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer
“Closed due to lack of drug availability.” - Preoperative Proton Radiotherapy for Retroperitoneal Sarcoma
“Study closed due to feasability”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.